HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Diffusion Weighted Imaging (DWI)

Diffusion-weighted imaging (DWI) is a specialized magnetic resonance imaging (MRI) technique that provides valuable information about the movement of water molecules within tissues. It is particularly useful for assessing the microstructural characteristics of tissues and detecting abnormalities in various medical conditions. In DWI, the MRI sequence applies diffusion-sensitizing gradients to the imaging process, allowing the visualization of the random motion of water molecules. This technique is highly sensitive to changes in tissue cellularity and integrity, making it especially effective in oncology for identifying and characterizing tumors, evaluating treatment response, and detecting metastatic lesions. Beyond oncology, DWI has applications in neuroimaging, where it aids in the early diagnosis of stroke, evaluation of neurodegenerative disorders, and assessment of inflammatory conditions affecting the brain and spinal cord. The versatility of DWI is further demonstrated in its utility for abdominal imaging, particularly in evaluating liver and pancreatic diseases. In the liver, DWI helps assess tissue vascularity, detect focal lesions, and differentiate benign from malignant lesions. In pancreatic imaging, DWI assists in characterizing pancreatic tumors and assessing their relationship with surrounding structures.

The quantitative nature of DWI, as seen in parameters like apparent diffusion coefficient (ADC), adds an additional layer of information for clinicians to interpret and aids in refining diagnoses. Ongoing research continues to explore and optimize DWI protocols, and its integration with other advanced imaging techniques enhances its diagnostic capabilities across various medical disciplines. As a non-invasive imaging modality, DWI has become an indispensable tool in clinical practice, offering unique insights into tissue microstructure and function. Its ability to provide information on cellular density and tissue organization makes DWI a valuable asset in the armamentarium of diagnostic radiology, contributing to the comprehensive assessment of diseases and guiding therapeutic decision-making in a wide range of medical specialties.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp